SoftBank forms AI healthcare JV in Japan with Tempus
How much did SoftBank invest in Tempus before its Nasdaq debut?
SoftBank invested around $200 million in Tempus in its series G funding round in April before Tempus listed on the Nasdaq in June3.
What initial medical focus will SB Tempus target in Japan?
SB Tempus will initially focus on oncology in Japan, aiming to provide personalized medical services through AI-powered data analysis. The company plans to collect and analyze patient genetic data from Japanese hospitals and universities to train AI patterns for patients in the country, offering hospitals processed data for clinical use and suggesting the best treatments4.
What unique services will SB Tempus offer to Japanese hospitals?
SB Tempus will offer three medical services to Japanese hospitals, utilizing AI to analyze personal medical data2. These services include genomic testing, medical data aggregation and analysis (genomic, clinical, pathology, and imaging data), and AI-driven treatment proposals. The company aims to provide personalized treatments and therapies by leveraging Tempus' expertise and technology in AI-powered healthcare.